5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate

C111H122Br3N35O17 — CID 160832646

IUPAC5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate
SMILESCC(=O)Oc1ccccc1C(=O)NCc1cn(C[C@@H]2CO2)nn1.CC(=O)Oc1ccccc1C(=O)NCc1cn(C[C@H]2CO2)nn1.CC(C)Cc1ccc(C(C)C(=O)NCc2cn(C[C@@H]3CO3)nn2)cc1.Cn1cc(C(=O)NCc2cn(C[C@@H]3CO3)nn2)c2cc(Br)ccc21.Cn1nc(C(=O)NCc2cn(CC3CC3)nn2)c2ccccc21.Cn1nc(C(=O)NCc2cn(C[C@@H]3CO3)nn2)c2cc(Br)ccc21.Cn1nc(C(=O)NCc2cn(C[C@H]3CO3)nn2)c2cc(Br)ccc21
InChIInChI=1S/C19H26N4O2.C16H16BrN5O2.C16H18N6O.2C15H15BrN6O2.2C15H16N4O4/c1-13(2)8-15-4-6-16(7-5-15)14(3)19(24)20-9-17-10-23(22-21-17)11-18-12-25-18;1-21-8-14(13-4-10(17)2-3-15(13)21)16(23)18-5-11-6-22(20-19-11)7-12-9-24-12;1-21-14-5-3-2-4-13(14)15(19-21)16(23)17-8-12-10-22(20-18-12)9-11-6-7-11;2*1-21-13-3-2-9(16)4-12(13)14(19-21)15(23)17-5-10-6-22(20-18-10)7-11-8-24-11;2*1-10(20)23-14-5-3-2-4-13(14)15(21)16-6-11-7-19(18-17-11)8-12-9-22-12/h4-7,10,13-14,18H,8-9,11-12H2,1-3H3,(H,20,24);2-4,6,8,12H,5,7,9H2,1H3,(H,18,23);2-5,10-11H,6-9H2,1H3,(H,17,23);2*2-4,6,11H,5,7-8H2,1H3,(H,17,23);2*2-5,7,12H,6,8-9H2,1H3,(H,16,21)/t14?,18-;12-;;2*11-;2*12-/m11.1010/s1
InChIKeySGZQUKWQHHUMQH-BJJLWFPBSA-N
MW2458.14 g/mol
LogP9.24
Rot. Bonds40

About 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate

5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate (PubChem CID 160832646) has the molecular formula C111H122Br3N35O17 and a molecular weight of 2458.14 g/mol. Its IUPAC name is 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate.

Molecular Properties

Compound Name5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate
PubChem CID160832646
Molecular FormulaC111H122Br3N35O17
Molecular Weight2458.14 g/mol
Exact Mass2453.73
IUPAC Name5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate
SMILESCC(=O)Oc1ccccc1C(=O)NCc1cn(C[C@@H]2CO2)nn1.CC(=O)Oc1ccccc1C(=O)NCc1cn(C[C@H]2CO2)nn1.CC(C)Cc1ccc(C(C)C(=O)NCc2cn(C[C@@H]3CO3)nn2)cc1.Cn1cc(C(=O)NCc2cn(C[C@@H]3CO3)nn2)c2cc(Br)ccc21.Cn1nc(C(=O)NCc2cn(CC3CC3)nn2)c2ccccc21.Cn1nc(C(=O)NCc2cn(C[C@@H]3CO3)nn2)c2cc(Br)ccc21.Cn1nc(C(=O)NCc2cn(C[C@H]3CO3)nn2)c2cc(Br)ccc21
InChIInChI=1S/C19H26N4O2.C16H16BrN5O2.C16H18N6O.2C15H15BrN6O2.2C15H16N4O4/c1-13(2)8-15-4-6-16(7-5-15)14(3)19(24)20-9-17-10-23(22-21-17)11-18-12-25-18;1-21-8-14(13-4-10(17)2-3-15(13)21)16(23)18-5-11-6-22(20-19-11)7-12-9-24-12;1-21-14-5-3-2-4-13(14)15(19-21)16(23)17-8-12-10-22(20-18-12)9-11-6-7-11;2*1-21-13-3-2-9(16)4-12(13)14(19-21)15(23)17-5-10-6-22(20-18-10)7-11-8-24-11;2*1-10(20)23-14-5-3-2-4-13(14)15(21)16-6-11-7-19(18-17-11)8-12-9-22-12/h4-7,10,13-14,18H,8-9,11-12H2,1-3H3,(H,20,24);2-4,6,8,12H,5,7,9H2,1H3,(H,18,23);2-5,10-11H,6-9H2,1H3,(H,17,23);2*2-4,6,11H,5,7-8H2,1H3,(H,17,23);2*2-5,7,12H,6,8-9H2,1H3,(H,16,21)/t14?,18-;12-;;2*11-;2*12-/m11.1010/s1
InChIKeySGZQUKWQHHUMQH-BJJLWFPBSA-N
XLogP9.24
TPSA604.84 Ų
H-Bond Donors7
H-Bond Acceptors45
Rotatable Bonds40
Heavy Atoms166
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002458.14
LogP ≤ 59.24
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1045

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phenol_ester', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate?
The IUPAC name of 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate (CID 160832646) is 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate.
What is the SMILES notation for 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate?
The canonical SMILES for 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate is CC(=O)Oc1ccccc1C(=O)NCc1cn(C[C@@H]2CO2)nn1.CC(=O)Oc1ccccc1C(=O)NCc1cn(C[C@H]2CO2)nn1.CC(C)Cc1ccc(C(C)C(=O)NCc2cn(C[C@@H]3CO3)nn2)cc1.Cn1cc(C(=O)NCc2cn(C[C@@H]3CO3)nn2)c2cc(Br)ccc21.Cn1nc(C(=O)NCc2cn(CC3CC3)nn2)c2ccccc21.Cn1nc(C(=O)NCc2cn(C[C@@H]3CO3)nn2)c2cc(Br)ccc21.Cn1nc(C(=O)NCc2cn(C[C@H]3CO3)nn2)c2cc(Br)ccc21.
What is the InChIKey of 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate?
The InChIKey is SGZQUKWQHHUMQH-BJJLWFPBSA-N. The full InChI is InChI=1S/C19H26N4O2.C16H16BrN5O2.C16H18N6O.2C15H15BrN6O2.2C15H16N4O4/c1-13(2)8-15-4-6-16(7-5-15)14(3)19(24)20-9-17-10-23(22-21-17)11-18-12-25-18;1-21-8-14(13-4-10(17)2-3-15(13)21)16(23)18-5-11-6-22(20-19-11)7-12-9-24-12;1-21-14-5-3-2-4-13(14)15(19-21)16(23)17-8-12-10-22(20-18-12)9-11-6-7-11;2*1-21-13-3-2-9(16)4-12(13)14(19-21)15(23)17-5-10-6-22(20-18-10)7-11-8-24-11;2*1-10(20)23-14-5-3-2-4-13(14)15(21)16-6-11-7-19(18-17-11)8-12-9-22-12/h4-7,10,13-14,18H,8-9,11-12H2,1-3H3,(H,20,24);2-4,6,8,12H,5,7,9H2,1H3,(H,18,23);2-5,10-11H,6-9H2,1H3,(H,17,23);2*2-4,6,11H,5,7-8H2,1H3,(H,17,23);2*2-5,7,12H,6,8-9H2,1H3,(H,16,21)/t14?,18-;12-;;2*11-;2*12-/m11.1010/s1.
What are the key properties of 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate?
5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate has a molecular weight of 2458.14 g/mol, XLogP of 9.24, 40 rotatable bonds, 7 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indazole-3-carboxamide;5-bromo-1-methyl-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]indole-3-carboxamide;N-[[1-(cyclopropylmethyl)triazol-4-yl]methyl]-1-methylindazole-3-carboxamide;2-[4-(2-methylpropyl)phenyl]-N-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methyl]propanamide;[2-[[1-[[(2R)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate;[2-[[1-[[(2S)-oxiran-2-yl]methyl]triazol-4-yl]methylcarbamoyl]phenyl] acetate is sourced from PubChem (CID 160832646), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).